Inventor · disambiguated record
Richard A. Hartz
Also filed as: HARTZ RICHARD A
22 granted patents·6 pending applications·36 citations·filing 2002–2022
92Inventor score
Files withBRISTOL MYERS SQUIBB CO14VIIV HEALTHCARE UK NO 4 LTD4VIIV HEALTHCARE UK NO 5 LTD4BRISTOL MYERS SQUIBB PHARMA CO3DZIERBA CAROLYN DIANE1
Top patents by PatentIndex Score
28 records- 0193US9527882B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2015·Granted Dec 27, 2016·6 cites·18 claims
- 0290US10752609B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 25, 2020·6 cites·10 claims
- 0385US11084845B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Aug 10, 2021·1 cites·8 claims
- 0483US10421774B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Granted Sep 24, 2019·1 cites·4 claims
- 0580US7319100B2Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Jan 15, 2008·3 cites·7 claims
- 0677US2023295220A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2022·Application pending·0 cites
- 0776US10780102B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Granted Sep 22, 2020·0 cites·3 claims
- 0876US10253027B2Aryl lactam kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 9, 2019·3 cites·6 claims
- 0973US7098217B23,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Aug 29, 2006·3 cites·7 claims
- 1071US2021323997A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 1169US10245275B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2017·Granted Apr 2, 2019·0 cites·4 claims
- 1266US7205306B2Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Apr 17, 2007·2 cites·16 claims
- 1366US7112585B2Pyrimidine derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 26, 2006·3 cites·16 claims
- 1466US7030145B2Pyridinyl derivatives for the treatment of depressionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 18, 2006·3 cites·11 claims
- 1565US9932320B2Quinoline-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 3, 2018·1 cites·10 claims
- 1665US6894045B2Tetrahydropurinones and derivatives thereof as corticotropin releasing factor receptor ligandsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted May 17, 2005·3 cites·27 claims
- 1765US2017056420A1Triterpenoids with hiv maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 1864US7932256B2(S)-4-(1-cyclopropyl-2-methoxyethyl)-6-(6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile: a pyrazinone modulator of corticotropin-releasing factor receptor activityBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 26, 2011·0 cites·2 claims
- 1959US8304577B2Modulators of G protein-coupled receptor 88DZIERBA CAROLYN DIANE·Filed 2010·Granted Nov 6, 2012·1 cites·4 claims
- 2055US2003119831A13,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligandsFiled 2002·Application pending·0 cites
- 2154US2016199372A1Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophreniaBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2252US8436000B2Substituted carbamate derivatives as modulators of corticotropin-releasing factor receptor activityHARTZ RICHARD A·Filed 2009·Granted May 7, 2013·0 cites·12 claims
- 2351US8372847B2Pyrazinone modulator of corticotropin-releasing factor receptor activityBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Feb 12, 2013·0 cites·5 claims
- 2450US10774086B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 15, 2020·0 cites·7 claims
- 2550US9249180B2C-3 alkyl and alkenyl modified betulinic acid derivativesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 2, 2016·0 cites·13 claims
- 2648US11970511B2Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 30, 2024·0 cites·23 claims
- 2735US10035777B2Heterocyclic kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 31, 2018·0 cites·12 claims
- 2835US2017239249A1Quinazoline-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard A. Hartz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →